A Study of Propranolol to Treat Kaposi Sarcoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Shane McAllister, Md, PhD
University of Minnesota Medical School Department of Pediatrics
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fundación Huésped
Buenos Aires, Argentina
Recruiting
- Instituto Nacional de Câncer José de Alencar
Rio de Janeiro, Brazil
Not, yet, recruiting - Complexo Hospitalar Universitário Professor Edgard Santos
Salvador, Brazil
Not, yet, recruiting
- Instituto Nacional de Cancerologia
Mexico City, Mexico
Patricia Volkow, MDNot, yet, recruiting
- Uganda Cancer Institute
Kampala, Uganda
Jackson Orem, MDNot, yet, recruiting
- University of Zimbabwe College of Health Sciences
Harare, Zimbabwe
Margaret Borok, MBChB (Hons) FRCP(UK)Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2026
- Primary completion
- 30 Sept 2028
- Completion
- 31 Mar 2029
- Last update posted
- 5 Oct 2026
- Registered enrollment
- 25
- Registry id
- NCT05797662
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.